Acute Hypercalcemia Management

Treat acute hypercalcemia as an emergency when there are neurologic manifestations, clinically important dehydration or renal dysfunction, or a serum calcium greater than 14 mg/dL. Symptoms with calcium greater than 12 mg/dL warrant urgent calcium-lowering measures; values above 14 mg/dL almost always require urgent intervention. PubMedPubMedApproach to Hypercalcemia - Endotext - NCBI Bookshelf - NIH Acute parathyroid crisis typically presents with severe hypercalcemia, usually above 14 mg/dL. Oxford AcademicOxford AcademicClassical and Nonclassical Manifestations of Primary ...

Confirm the abnormality with ionized calcium when albumin-corrected or total calcium may misclassify the patient, particularly with acid-base disturbance, dysproteinemia, or substantial citrate exposure from blood products. Ionized calcium is more sensitive and specific than total or corrected calcium, whereas corrected calcium is only an approximation and depends on local calcium and albumin assays. ScienceDirect+1ScienceDirectInvestigation of hypercalcemiaScienceDirectDisorders of Calcium Metabolism - an overview

Obtain intact PTH during the initial etiologic workup; it is the most important differential diagnostic test. Simultaneously assess creatinine and serum phosphorus, because renal impairment changes escalation options and hypophosphatemia often accompanies hypercalcemia and should be monitored and repleted. ScienceDirect+1ScienceDirectInvestigation of hypercalcemiaPubMedMalignancy-Related Hypercalcemia - StatPearls - NCBI Bookshelf

Begin intravenous isotonic saline to restore euvolemia in severe or symptomatic hypercalcemia. Volume restoration is the first acute intervention because hypercalcemia can produce dehydration and renal impairment; in vitamin D-mediated severe symptomatic hypercalcemia, initial treatment likewise begins with intravenous isotonic saline. PubMed+1PubMedApproach to Hypercalcemia - Endotext - NCBI Bookshelf - NIHPubMedVitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment - PMC

For severe hypercalcemia of malignancy, combine calcitonin with either denosumab or an intravenous bisphosphonate as initial therapy. Calcitonin provides a short treatment bridge but should be limited to 48 to 72 hours because response diminishes thereafter. endocrinenews endocrineendocrinenews endocrineNew Endocrine Society Guideline Suggests Hypercalcemia of Malignancy Treatment Options - Endocrine News

Select an antiresorptive early when hypercalcemia is malignancy-associated or mediated by increased bone resorption. The Endocrine Society recommends either denosumab or an IV bisphosphonate for adults with hypercalcemia of malignancy and suggests denosumab over an IV bisphosphonate based on limited indirect evidence. Denosumab is not renally cleared and is an important option when kidney impairment limits bisphosphonate use. PubMed+2PubMedTreatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline - PubMedPubMedDenosumab as a treatment for pediatric hypercalcemia—a multicenter experienceendocrinenews endocrineNew Endocrine Society Guideline Suggests Hypercalcemia of Malignancy Treatment Options - Endocrine News

Do not use loop diuretics as a substitute for rehydration. A loop diuretic may be added only after adequate hydration in severe symptomatic vitamin D-mediated hypercalcemia; monitor electrolytes when calciuresis is pursued. PubMedPubMedVitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment - PMC

Interpret an intact PTH that is not suppressed in hypercalcemia as a PTH-dependent pattern and pursue parathyroid-mediated disease. Severe primary hyperparathyroidism can present as hypercalcemic crisis, and persistent severe hypercalcemia despite intravenous fluids, bisphosphonate therapy, and calcitonin may require definitive parathyroidectomy after stabilization. ScienceDirect+2ScienceDirectInvestigation of hypercalcemiaOxford AcademicClassical and Nonclassical Manifestations of Primary ...PubMedPrimary hyperparathyroidism presenting as acute hypercalcemic crisis: a case report - PMC

A suppressed PTH redirects evaluation toward PTH-independent hypercalcemia. In a patient with cancer, distinguish humoral hypercalcemia from tumor PTHrP secretion, local osteolytic hypercalcemia from bone metastasis–associated osteoclast activation, calcitriol-mediated hypercalcemia associated with lymphoma, and the rare entity of ectopic tumor PTH production. BMJBMJHypercalcemia of malignancy - Symptoms, diagnosis and treatment | BMJ Best Practice US

Order PTHrP when humoral hypercalcemia of malignancy is suspected and measure calcitriol, 1,25-dihydroxyvitamin D, when lymphoma or another calcitriol-producing process is plausible. A rising calcitriol concentration with resistance to bisphosphonate and denosumab should prompt reconsideration of calcitriol-mediated disease. BMJ+1BMJHypercalcemia of malignancy - Symptoms, diagnosis and treatment | BMJ Best Practice USWileyHypercalcemia of Malignancy in Thymic Carcinoma: Evolving ...

Persistent severe hypercalcemia after fluids, calcitonin, and antiresorptive treatment should trigger reassessment for an unaddressed source of PTH, calcitriol excess, continued tumor activity, or inability to clear calcium because of renal dysfunction. Dialysis is appropriate for refractory severe hypercalcemia or renal insufficiency and can lower ionized calcium over hours. BMJ+1BMJHypercalcemia of malignancy - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedApproach to Hypercalcemia - Endotext - NCBI Bookshelf - NIH

For recurrent hypercalcemia of malignancy after IV bisphosphonate therapy, use denosumab. In contrast, calcitonin should not be extended beyond 48 to 72 hours because tachyphylaxis limits continued effect. endocrinenews endocrineendocrinenews endocrineNew Endocrine Society Guideline Suggests Hypercalcemia of Malignancy Treatment Options - Endocrine News

For PTH-dependent crisis from primary hyperparathyroidism, calcium-lowering medications may bridge to source control but do not replace definitive parathyroidectomy when crisis remains refractory. Case-based experience describes ongoing severe hypercalcemia despite intravenous fluids, bisphosphonates, and calcitonin, with surgical intervention required for resolution. Oxford Academic+1Oxford AcademicHypercalcemic Crisis in Pregnancy With Acute Respiratory Distress ...PubMedPrimary hyperparathyroidism presenting as acute hypercalcemic crisis: a case report - PMC

For hypercalcemia of malignancy, durable control requires treatment of the underlying cancer; pharmacologic therapy is transient if tumor activity persists. BMJ+1BMJHypercalcemia of malignancy - Symptoms, diagnosis and treatment | BMJ Best Practice USPubMedTreatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline - PubMed